Overview
Human Angiotensin converting enzyme 2 (ACE2) is the entry point for COVID-19 (SARS-CoV-2) due to its interaction with the coronavirus Spike protein. To accelerate your COVID-19 research, we provide premade HEK293T/ACE2 stable cell line. HEK293T/ACE2 stable cell line is generated by transducing HEK293T cells with our premade ACE2 lentivirus (CMV, Puro). Combined with SARS-CoV-2 spike protein pseudotyped GFP, RFP, firefly luciferase or GFP-Firefly luciferase lentiviruses, it provides a model for studying COVID-19 entry of cells and screening of drugs to block COVID-19 entry.
Features:
- Validated for ACE2 expression and COVID-19 spike protein- pseudotyped lentivirus entry
- In vitro model for screening antibody or inhibitors to block COVID-19 infection
Product Details
| Package Size | 2 x 10^6 cells |
| Parental cell line | HEK293T cells |
| Transgenic gene | Human ACE2 |
| Mammalian selection | Puromycin |
| Biosafety level | 2 |
| Storage | Liquid nitrogen |
| Availability | In stock |
| Shipping condition | dry ice |